Defining the molecular landscape of ependymomas.

Cancer Cell
Authors
Keywords
Abstract

Ependymomas have a variable prognosis. In this issue of Cancer Cell, Pajtler and colleagues identify nine subgroups of ependymoma using DNA methylation profiles. Two subgroups, predominately pediatric, are responsible for most of the mortality, with all others having nearly 100% overall survival after 5 years.

Year of Publication
2015
Journal
Cancer Cell
Volume
27
Issue
5
Pages
613-5
Date Published
2015 May 11
ISSN
1878-3686
URL
DOI
10.1016/j.ccell.2015.04.015
PubMed ID
25965568
Links